Argentina Formally Starts Producing Russia’s Sputnik Vaccine
(Bloomberg) -- Argentina and Russia's president formally announced Friday that a pharmaceutical company in the South American nation will start producing the Sputnik V Covid-19 vaccine.
Presidents Vladimir Putin and Alberto Fernandez spoke in a webcast event to kick off the vaccine's production at Laboratorios Richmond S.A. in Buenos Aires. Ties between the two nations have deepened after Fernandez agreed to buy the Sputnik vaccine, developed by Russia's Gamaleya Institute. Argentina was at one point the only country outside of the former Soviet Union to inoculate its citizens with the shot.
“In Argentina, we say we get to know our friends in difficult times,” Fernandez said at the event. “And when we were going through a difficult time, the Russian government, Russia's sovereign fund and the Gamaleya Institute stood by our side.”
Read More: Biden Team to Send 25 Million Doses of U.S. Vaccines Abroad (2)
Argentina bet big on Sputnik last year as talks with other labs hit snags and production of the AstraZeneca vaccine in Latin America faced major delays. The country has received 8.9 million Sputnik doses this year, accounting for nearly half of its total vaccines, including 7.79 million doses of the first shot, and 1.14 million of the second.
The campaign faced public skepticism until a peer-reviewed study by the Lancet medical journal said the vaccine protects against the deadly virus about as well as U.S. and European shots, and far more effectively than Chinese rivals. Now, critics caution against growing delays in receiving the second dose to complete the inoculation process.
Before Argentine pharmaceutical regulators even approved the Russian vaccine in December, Fernandez had already sent a plane from state-run Aerolineas Argentinas to Moscow to pick up the first batch. In total, the airline has sent more than 15 passenger planes since December to Russia on 40-hour journeys to pick up vaccines.
Fernandez, who received both Sputniks jabs himself, set expectations high last December, promising to vaccinate 10 million Argentines with Sputnik before the end of February, a threshold vaccinations only crossed in recent days
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.